Unity Biotechnology, Inc.
UBXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001463361
Unity Biotechnology, Inc. was delisted in 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 35
- Q2 2025, −5 vs. previous quarter
- 13F value
- $987.3K
- Reported value at the end of Q2 2025
- Superinvestors holding
- 0
- At the end of Q2 2025
Superinvestors holding UBX, Q2 2025
No superinvestor reported holding UBX at the end of Q2 2025.
Latest insider trades
Open-market purchases and sales by Unity Biotechnology, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 (view filing) | Apr 2 | 1 day | Nguyen Alexander HieuCLO and Head of Ops | SSaleCommon Stock, $0.0001 par value | −17.9K | $1.03 | −$18.4K | −26.8%48.8K after | |
| Apr 3, 2025 (view filing) | Apr 2 | 1 day | Sullivan Lynne MarieCFO & Head of Corp. Dev. | SSaleCommon Stock, $0.0001 par value | −21.9K | $1.03 | −$22.5K | −18.1%98.9K after | |
| Apr 3, 2025 (view filing) | Apr 2 | 1 day | Ghosh AnirvanChief Executive Officer | SSaleCommon Stock, $0.0001 par value | −96.8K | $1.03 | −$99.7K | −38.7%153.5K after | |
| Mar 31, 2025 (view filing) | Mar 27 | 4 days | Nguyen Alexander HieuCLO and Head of Ops | SSaleCommon Stock, $0.0001 par value | −1.95K | $1.16 | −$2.27K | −8.0%22.6K after | |
| Feb 5, 2025 (view filing) | Feb 4 | 1 day | Sullivan Lynne MarieCFO & Head of Corp. Dev. | SSaleCommon Stock, $0.0001 par value | −153 | $2.23 | −$341.19 | −0.3%55.8K after | |
| Feb 5, 2025 (view filing) | Feb 4 | 1 day | Nguyen Alexander HieuCLO and Head of Ops | SSaleCommon Stock, $0.0001 par value | −164 | $2.23 | −$365.72 | −0.7%24.6K after | |
| Feb 5, 2025 (view filing) | Feb 4 | 1 day | Ghosh AnirvanChief Executive Officer | SSaleCommon Stock, $0.0001 par value | −642 | $2.23 | −$1.43K | −0.8%75.3K after | |
| Nov 6, 2024 (view filing) | Nov 4 | 2 days | Sullivan Lynne MarieCFO & Head of Corp. Dev. | SSaleCommon Stock, $0.0001 par value | −136 | $1.29 | −$175.44 | −0.2%55.9K after | |
| Nov 6, 2024 (view filing) | Nov 4 | 2 days | Nguyen Alexander HieuChief Legal Officer | SSaleCommon Stock, $0.0001 par value | −149 | $1.29 | −$192.21 | −0.6%24.7K after | |
| Nov 6, 2024 (view filing) | Nov 4 | 2 days | Ghosh AnirvanChief Executive Officer | SSaleCommon Stock, $0.0001 par value | −432 | $1.29 | −$557.28 | −0.6%75.9K after |
Top 10 13F holders, Q2 2025
The largest institutional positions in Unity Biotechnology, Inc. at the end of Q2 2025; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ARCH Venture Management, LLC | 1,004,817 | $385.9K | 0.13% | 00.0% | Unchanged |
| Vanguard Group Inc | 673,090 | $255.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 169,025 | $64.2K | 0.00% | +2,812+1.7% | Added |
| UBS Group AG | 152,327 | $58.5K | 0.00% | +128,026+526.8% | Added |
| Renaissance Technologies LLC | 98,311 | $37.8K | 0.00% | +4,100+4.4% | Added |
| BlackRock, Inc. | 81,402 | $31.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 60,556 | $23.3K | 0.00% | +17,200+39.7% | Added |
| Susquehanna International Group, LLP | 56,720 | $21.6K | 0.00% | −6,016−9.6% | Reduced |
| Founders Fund V Management, LLC | 49,172 | $18.7K | 1.36% | 00.0% | Unchanged |
| State Street Corp | 37,824 | $14.4K | 0.00% | 00.0% | Unchanged |